• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SAGE

SAGE

Sage Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD8.68

+0.00 (+0.00%)

Company Profile

CEO

Barry E. Greene

IPO Date

2014-07-18

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$8.68

Prev. Close

$8.68

Day Low

$8.68

Day High

$8.68

52W Low

$4.62

52W High

$9.36

Market Cap

$0.54B

Volume

17.39M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBearish

Articles

10

Avg Positive

6.5%

Avg Negative

42.6%

Avg Neutral

50.7%

News Feed

Sage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks Investment Research·7/27/2021·↑ positive

Sage Therapeutics to Report Second Quarter 2021 Financial Results on Tuesday, August 3, 2021

Business Wire·7/20/2021·↑ positive

Sage Therapeutics to Participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsychiatry Summit

Business Wire
·7/8/2021
·↑ positive

Sage Therapeutics to Participate in SVB Leerink's 3rd Annual CNS Forum

Business Wire·6/24/2021·↑ positive

What Happened to Sage Therapeutics Stock?

The Motley Fool·6/21/2021·↓ negative

Here's Why Sage Therapeutics Tanked This Week

The Motley Fool·6/19/2021·↓ negative

Here's Why Sage Therapeutics Stock Is Sliding Today

The Motley Fool·6/15/2021·↓ negative

Here's why Sage Therapeutics fell 18% on Tuesday morning

Invezz·6/15/2021·↓ negative

SAGE Plummets After Drug Trial Results

Schaeffers Research·6/15/2021·↓ negative

SAGE Stock Price Falls Over 10% Pre-Market: Why It Happened

Pulse2·6/15/2021·↓ negative